Zelle Biotechnology Profile
Key Indicators
- Authorised Capital ₹ 0.60 M
as on 22-12-2024
- Paid Up Capital ₹ 0.10 M
as on 22-12-2024
- Company Age 20 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 77.23%
(FY 2022)
- Profit 157.73%
(FY 2022)
- Ebitda 85.69%
(FY 2022)
- Net Worth 89.31%
(FY 2022)
- Total Assets 62.30%
(FY 2022)
About Zelle Biotechnology
The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.60 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Sudhir Tulsyan, Anurag Tulsyan, and Deepti Tulsyan serve as directors at the Company.
- CIN/LLPIN
U24230MH2004PTC148958
- Company No.
148958
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
04 Oct 2004
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- LocationMira Road, Maharashtra
- Telephone
- Email Address
- Website
- Social Media
What products or services does Zelle Biotechnology Private Limited offer?
Zelle Biotechnology Private Limited offers a wide range of products and services, including Surgical & ICU Equipments, Patient Monitoring System, Software Development & IT Consultant, Malware Removal Services.
Who are the key members and board of directors at Zelle Biotechnology?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anurag Tulsyan  | Managing Director | 04-Oct-2004 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sudhir Tulsyan | Director | 04-Oct-2004 | Current |
| Deepti Tulsyan | Whole-Time Director | 28-Jan-2022 | Current |
Financial Performance of Zelle Biotechnology.
Zelle Biotechnology Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 77.23% increase. The company also saw a substantial improvement in profitability, with a 157.73% increase in profit. The company's net worth Soared by an impressive increase of 89.31%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Zelle Biotechnology?
In 2021, Zelle Biotechnology had a promoter holding of 60.00% and a public holding of 40.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Stay Sharp Diamond Tools Pvt LtdActive 41 years 9 monthsSudhir Tulsyan and Anurag Tulsyan are mutual person
Shatul Commercial Company Private LimitedActive 34 years 9 monthsSudhir Tulsyan and Anurag Tulsyan are mutual person
- Suditul Trading And Investment Company Private LimitedActive 34 years 9 months
Sudhir Tulsyan, Anurag Tulsyan and 1 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Zelle Biotechnology?
Zelle Biotechnology has a workforce of 65 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Zelle Biotechnology, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Zelle Biotechnology's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
